Activist Investor Bill Ackman Defends Support For Drug Maker Valeant
The New York Times interviews Ackman, who backs Valeant and the company's controversial drug pricing practices. In other marketplace news, U.S. prosecutors seek to extradite pharmacy officials charged with smuggling counterfeit cancer drugs.
The New York Times' DealBook:
Bill Ackman’s Enigmatic Approach To Valeant Pharmaceuticals
William A. Ackman, the activist investor, has described his billion-dollar bet and continuing crusade against the nutritional supplements company Herbalife as a “moral obligation.” In at least one presentation, he nearly cried onstage and said that if his Herbalife trade was successful, he would give the profits to charity because he would consider them “blood money.” (Sorkin, 11/9)
The Associated Press:
U.S. To Ask Canada, UK To Extradite Online Pharmacy Officials
U.S. prosecutors plan to ask the Canadian and British governments to extradite officials with an online pharmacy on charges of smuggling $78 million worth of mislabeled, unapproved and counterfeit cancer drugs into the country to sell to doctors. Fourteen companies and individuals from Canada, the United Kingdom, Barbados and the U.S. are accused of participating in the conspiracy that involved falsifying customs declarations for shipments from the U.K., according to the criminal indictment. (Volz, 11/9)